Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform
Industry veterans including Craig Lipset will support Castor’s vision to advance the future of clinical research
Amsterdam, Netherlands and Hoboken, New Jersey: November 18, 2019: Castor, a health-tech company that aims to leverage machine readable data to increase clinical trial efficiency, today announces the formation of an independent Advisory Board.
Castor’s Electronic Data Capture (EDC) platform enables every researcher worldwide to easily capture and integrate medical research data from any source in real-time, including clinicians, patients, devices, wearables, and electronic health record (EHR) systems. Researchers on the platform generate vast amounts of data from traditional and decentralized trials, and Castor recently reached milestones of 100,000,000 data points and 1,000,000 enrolled patients.
